Authors:
KOJO A
PELLINEN P
JUVONEN R
RAUNIO H
PELKONEN O
PASANEN M
Citation: A. Kojo et al., DISTINCT RESPONSES OF MOUSE HEPATIC CYP ENZYMES TO CORN-OIL AND PEROXISOME PROLIFERATORS, Biochemical pharmacology, 51(9), 1996, pp. 1137-1143
Authors:
HAKKOLA J
PASANEN M
HUKKANEN J
PELKONEN O
MAENPAA J
EDWARDS RJ
BOOBIS AR
RAUNIO H
Citation: J. Hakkola et al., EXPRESSION OF XENOBIOTIC-METABOLIZING CYTOCHROME-P450 FORMS IN HUMAN FULL-TERM PLACENTA, Biochemical pharmacology, 51(4), 1996, pp. 403-411
Citation: O. Pelkonen et H. Raunio, INDIVIDUAL EXPRESSION OF CARCINOGEN-METABOLIZING ENZYMES - CYTOCHROMEP4502A, Journal of occupational and environmental medicine, 37(1), 1995, pp. 19-24
Authors:
ALAKOKKO TI
PIENIMAKI P
HERVA R
HOLLMEN AI
PELKONEN O
VAHAKANGAS K
Citation: Ti. Alakokko et al., TRANSFER OF LIDOCAINE AND BUPIVACAINE ACROSS THE ISOLATED-PERFUSED HUMAN PLACENTA, Pharmacology & toxicology, 77(2), 1995, pp. 142-148
Authors:
KLEBOVICH I
RAUTIO A
SALONPAA P
ARVELA P
PELKONEN O
SOTANIEMI EA
Citation: I. Klebovich et al., ANTIPYRINE, COUMARIN AND GLIPIZIDE AFFECT N-ACETYLATION MEASURED BY CAFFEINE TEST, Biomedicine & pharmacotherapy, 49(5), 1995, pp. 225-227
Authors:
RAUNIO H
HUSGAFVELPURSIAINEN K
ANTTILA S
HIETANEN E
HIRVONEN A
PELKONEN O
Citation: H. Raunio et al., DIAGNOSIS OF POLYMORPHISMS IN CARCINOGEN-ACTIVATING AND INACTIVATING ENZYMES AND CANCER SUSCEPTIBILITY - A REVIEW, Gene, 159(1), 1995, pp. 113-121
Authors:
RASMUSSEN BB
MAENPAA J
PELKONEN O
LOFT S
POULSEN HE
LYKKESFELDT J
BROSEN K
Citation: Bb. Rasmussen et al., SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND THEOPHYLLINE METABOLISM IN HUMAN LIVER-MICROSOMES - POTENT INHIBITION BY FLUVOXAMINE, British journal of clinical pharmacology, 39(2), 1995, pp. 151-159
Authors:
SOTANIEMI EA
RAUTIO A
BACKSTROM M
ARVELA P
PELKONEN O
Citation: Ea. Sotaniemi et al., CYP3A4 AND CYP2A6 ACTIVITIES MARKED BY THE METABOLISM OF LIGNOCAINE AND COUMARIN IN PATIENTS WITH LIVER AND KIDNEY-DISEASES AND EPILEPTIC PATIENTS, British journal of clinical pharmacology, 39(1), 1995, pp. 71-76
Authors:
ISOJARVI JIT
PAKARINEN AJ
RAUTIO A
PELKONEN O
MYLLYLA VV
Citation: Jit. Isojarvi et al., SERUM SEX-HORMONE LEVELS AFTER REPLACING CARBAMAZEPINE WITH OXCARBAZEPINE, European Journal of Clinical Pharmacology, 47(5), 1995, pp. 461-464
Citation: P. Salonpaa et al., UP-REGULATION OF CYP2A5 EXPRESSION BY PORPHYRINOGENIC AGENTS IN MOUSE-LIVER, Naunyn-Schmiedeberg's archives of pharmacology, 351(4), 1995, pp. 446-452
Authors:
ISOJARVI JIT
AIRAKSINEN KEJ
MUSTONEN JN
PAKARINEN AJ
RAUTIO A
PELKONEN O
MYLLYLA VV
Citation: Jit. Isojarvi et al., THYROID AND MYOCARDIAL-FUNCTION AFTER REPLACEMENT OF CARBAMAZEPINE BYOXCARBAZEPINE, Epilepsia, 36(8), 1995, pp. 810-816
Authors:
PIENIMAKI P
HARTIKAINEN AL
ARVELA P
PARTANEN T
HERVA R
PELKONEN O
VAHAKANGAS K
Citation: P. Pienimaki et al., CARBAMAZEPINE AND ITS METABOLITES IN HUMAN PERFUSED PLACENTA AND IN MATERNAL AND CORD-BLOOD, Epilepsia, 36(3), 1995, pp. 241-248
Authors:
FERNANDEZSALGUERO P
HOFFMAN SMG
CHOLERTON S
MOHRENWEISER H
RAUNIO H
RAUTIO A
PELKONEN O
HUANG JD
EVANS WE
IDLE JR
GONZALEZ FJ
Citation: P. Fernandezsalguero et al., A GENETIC-POLYMORPHISM IN COUMARIN 7-HYDROXYLATION - SEQUENCE OF THE HUMAN CYP2A GENES AND IDENTIFICATION OF VARIANT CYP2A6 ALLELES, American journal of human genetics, 57(3), 1995, pp. 651-660
Citation: M. Pasanen et O. Pelkonen, THE EXPRESSION AND ENVIRONMENTAL-REGULATION OF P450 ENZYMES IN HUMAN PLACENTA, Critical reviews in toxicology, 24(3), 1994, pp. 211-229
Authors:
PELLINEN P
STENBACK F
RAUNIO H
PELKONEN O
PASANEN M
Citation: P. Pellinen et al., MODIFICATION OF HEPATIC CYTOCHROME-P450 PROFILE BY COCAINE-INDUCED HEPATOTOXICITY IN DBA 2 MOUSE/, European journal of pharmacology. Environmental toxicology and pharmacology section, 292(1), 1994, pp. 57-65
Authors:
PELLINEN P
STENBACK F
RAUNIO H
PELKONEN O
PASANEN M
Citation: P. Pellinen et al., MODIFICATION OF HEPATIC CYTOCHROME-P450 PROFILE BY COCAINE-INDUCED HEPATOTOXICITY IN DBA 2 MOUSE/, European journal of pharmacology. Environmental toxicology and pharmacology section, 292(1), 1994, pp. 57-65
Authors:
PELLINEN P
HONKAKOSKI P
STENBACK F
NIEMITZ M
ALHAVA E
PELKONEN O
LANG MA
PASANEN M
Citation: P. Pellinen et al., COCAINE N-DEMETHYLATION AND THE METABOLISM-RELATED HEPATOTOXICITY CANBE PREVENTED BY CYTOCHROME-P450 3A INHIBITORS, European journal of pharmacology. Environmental toxicology and pharmacology section, 270(1), 1994, pp. 35-43
Authors:
NAKAJIMA T
ELOVAARA E
GONZALEZ FJ
GELBOIN HV
RAUNIO H
PELKONEN O
VAINIO H
AOYAMA T
Citation: T. Nakajima et al., STYRENE METABOLISM BY CDNA-EXPRESSED HUMAN HEPATIC AND PULMONARY CYTOCHROMES P450, Chemical research in toxicology, 7(6), 1994, pp. 891-896
Authors:
ISCAN M
ROSTAMI H
ISCAN M
GURAY T
PELKONEN O
RAUTIO A
Citation: M. Iscan et al., INTERINDIVIDUAL VARIABILITY OF COUMARIN 7-HYDROXYLATION IN A TURKISH POPULATION, European Journal of Clinical Pharmacology, 47(4), 1994, pp. 315-318
Authors:
ISOJARVI JIT
PAKARINEN AJ
RAUTIO A
PELKONEN O
MYLLYLA VV
Citation: Jit. Isojarvi et al., LIVER-ENZYME INDUCTION AND SERUM-LIPID LEVELS AFTER REPLACEMENT OF CARBAMAZEPINE WITH OXCARBAZEPINE, Epilepsia, 35(6), 1994, pp. 1217-1220
Authors:
MUSTAJOKI P
MUSTAJOKI S
RAUTIO A
ARVELA P
PELKONEN O
Citation: P. Mustajoki et al., EFFECTS OF HEME ARGINATE ON CYTOCHROME-P450 - MEDIATED METABOLISM OF DRUGS IN PATIENTS WITH VARIEGATE PORPHYRIA AND IN HEALTHY-MEN, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 9-13
Authors:
MAENPAA J
JUVONEN R
RAUNIO H
RAUTIO A
PELKONEN O
Citation: J. Maenpaa et al., METABOLIC INTERACTIONS OF METHOXSALEN AND COUMARIN IN HUMANS AND MICE, Biochemical pharmacology, 48(7), 1994, pp. 1363-1369
Authors:
HAKKOLA J
PASANEN M
PURKUNEN R
SAARIKOSKI S
PELKONEN O
MAENPAA J
RANE A
RAUNIO H
Citation: J. Hakkola et al., EXPRESSION OF XENOBIOTIC-METABOLIZING CYTOCHROME-P450 FORMS IN HUMAN ADULT AND FETAL LIVER, Biochemical pharmacology, 48(1), 1994, pp. 59-64